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“Next generation sequencing identifies
mutations in GNPTG gene as a cause of
familial form of scleroderma-like disease”
Afolake T. Arowolo*, Henry A. Adeola and Nonhlanhla P. Khumalo
Dear Editor,
With great interest, we read Zrhidri et al.’s paper [1]
which reports compound heterozygous mutations in
exon 4 and 9 of the GNPTG gene, in a familial
scleroderma-like disease. This novel finding represents
an important addition to the family of genetic mutations
previously associated with multisystemic fibrosis and
scleroderma-like diseases in literature. Further, elucidat-
ing pathogenetic mechanisms of genetic systemic fibrosis
could potentially lead to discovery of effective treatment
of auto-immune systemic sclerosis and related diseases,
and alleviate severe morbidity and mortality.
Although the authors focused on scleroderma-like man-
ifestations found in Mucolipidosis type III (pseudo-Hurler
polydystrophy), it would have also been useful to mention
other genes associated with a scleroderma-like phenotype
in their study discussion. Some examples are listed below:
 FAM 111B gene for scleroderma and multisystemic
fibrosis-like hereditary fibrosing poikiloderma with
tendon contractures, myopathy, and pulmonary
fibrosis (POIKTMP) [2]
 RECQL4 gene for Rothmund Thomson Syndrome
(RTS) [3],
 WRN gene for Werner syndrome (WS) [4]
 LMNA gene in Hutchinson-Gilford progeria
syndrome (HGPS) [5]
Finally, considering the multifactorial etiology of fibrosis,
it would be interesting to see how the new gene (GNPTG)
compares to other genes involved in scleroderma-like
diseases such as FAM 111B (POIKTMP), RECLQL4
(RTS), WRN (WS) and LMNA (HGPS); and if there are
possible gene interactions, considering the similarities in
the phenotype produced.
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